In addition to increasing numbers of studies related to CTLA-4 therapy resistance, many new investigations aimed to delineate the fundamental mechanisms of PD-1/PD-L1-dependant immune tolerance in HCC [71,154]. This evidence concerns the gene CD274 and hepatocellular carcinoma.